AD-212
/ Yuhan Corp
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
August 01, 2024
A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-212-A and AD-2121
(clinicaltrials.gov)
- P1 | N=24 | Completed | Sponsor: Addpharma Inc. | Recruiting ➔ Completed
Trial completion • Gastroenterology • Gastroesophageal Reflux Disease
February 01, 2024
A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-212-A and AD-2121
(clinicaltrials.gov)
- P1 | N=24 | Recruiting | Sponsor: Addpharma Inc. | Not yet recruiting ➔ Recruiting
Enrollment open • Gastroenterology • Gastroesophageal Reflux Disease
September 06, 2023
A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-212-A and AD-2121
(clinicaltrials.gov)
- P1 | N=24 | Not yet recruiting | Sponsor: Addpharma Inc.
New P1 trial • Gastroenterology • Gastroesophageal Reflux Disease
1 to 3
Of
3
Go to page
1